Unomedical, which supplies diabetes tech firms including Medtronic, Tandem Diabetes Care and Beta Bionics, received more than 5,000 complaints about leaking infusion sets between 2023 and 2025.
In its second safety alert this year, Smiths Medical has issued a letter to its customers detailing a pair of potential issues with the infusion sets used alongside its CADD line of infusion systems.
IRVINE, Calif.--(BUSINESS WIRE)--Medical device developer Capillary Biomedical, Inc. (CapBio) has presented highly favorable clinical feasibility study results for its SteadiFlow cannula technology at ...
Medtronic is telling patients that certain lots of its infusion sets for its insulin pumps are being recalled as part of a voluntary effort. The problematic infusion sets, which patients can identify ...
ICU Medical is recalling some lots of its Plum and Sapphire Microbore infusion sets due to the potential for fluid leaks. The infusion sets have the potential for small amounts of fluid to leak out of ...
The problem caused an overdelivery of insulin in some cases. A design update in April 2017 corrected the problem but some patients still have lots of defective infusion sets. Medtronic today announced ...
ConvaTec is a leading global manufacturer of widely popular infusion sets offering a variety of patient choice Beta Bionics is developer of the iLet Bionic Pancreas System and is committed to device ...
Certain Medtronic MiniMed Paradigm Insulin Infusion sets are being recalled, the Food and Drug Administration announced on Friday. The affected products were manufactured between October 2001 and June ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A novel extended-wear insulin infusion set was usable ...
Medtronic, an Ireland-based medical device firm with an a location in Littleton, announced Monday a recall of infusion sets with all models of the company’s insulin pumps. The recall includes a ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today announced its acquisition of infusion set developer, Capillary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results